Navigation Links
Whistleblower Doctor Comments on His Case that Helped Expose Illegal Marketing of Topamax
Date:4/29/2010

Doctor is one of few physicians to blow whistle on pharma industry

WASHINGTON, April 29 /PRNewswire-USNewswire/ -- One of the two whistleblower lawsuits that is being settled as part of Ortho-McNeil-Janssen Pharmaceuticals Inc.'s and Ortho-McNeil Pharmaceutical LLC's $81 million settlement announced today was filed by Dr. Gary R. Spivack, a psychiatrist from northern Virginia.

Below are statements from:

  • Dr. Spivack, who is one of the few doctors to blow the whistle on the pharma industry.
  • Erika A. Kelton, a Washington, DC, attorney with Phillips & Cohen LLP, which represents the whistleblower. Ms. Kelton and her law firm also represented the whistleblower in a qui tam lawsuit that exposed Pfizer's illegal marketing of the painkiller Bextra for "off-label" uses that endangered patients' lives and health. Pfizer last year paid a record-setting $1.8 billion to settle that case and a related criminal charge as part of a global settlement totaling $2.3 billion.

Resources (links):


Statement from Dr. Gary R. Spivack:

"I found it outrageous that Ortho-McNeil would try to pay doctors to influence them to prescribe a drug for uses that clearly endangered patents' health. Doctors need impartial and accurate information to make decisions on the best treatment for their patients, but that's not what Ortho-McNeil provided."

Statement from attorney Erika A. Kelton of Phillips & Cohen LLP:

"Pharma companies pay doctors 'consulting fees' and other inducements because that money tends to make doctors more willing to prescribe their products based on information from pharma companies. But we've seen numerous instances in recent years where pharma companies have misled doctors, putting profits ahead of patient safety."

"The government -- particularly Assistant U.S. Attorney Zachary Cunha and Trial Attorney Colin Huntley -- did a great job investigating and resolving this significant matter."

About Dr. Spivack's qui tam case:

The FDA had approved Topamax only to treat certain conditions: as therapy for patients that suffer from certain types of seizures. Dr. Spivack alleged in his qui tam lawsuit that Ortho-McNeil paid doctors kickbacks to encourage them to prescribe Topamax for a wide range of "off-label" uses – such as for weight loss, alcohol dependence, eating disorders and mood and anxiety disorders  -- despite serious risks to patients' health. "Off-label" uses are those uses that haven't been approved by the Federal Drug Administration.

Dr. Spivack became aware of Ortho-McNeil's national campaign to promote the use of Topamax for off-label uses when he attended a "Psychiatry Consultants' Conference" sponsored by the pharma company. Attendees were paid $500 each or more as "consultants" to attend the meeting and listen to company presentations.

The vast majority of presentations at the conference concerned off-label uses of Topamax and claims about the effectiveness of Topamax for unapproved uses. Under the FDA law, drug manufacturers are prohibited from making exaggerated, unsupported or misleading claims as to the efficacy of their drugs.

Phillips & Cohen filed Dr. Spivack's qui tam case, brought under the False Claims Act, in December 2003 in federal district court in New York City.

Case citation: United States ex rel. Spivack v. Johnson & Johnson and Ortho-McNeil Pharmaceutical, Inc., Civil Action No. 04-11886-WGY

About Phillips & Cohen LLP

Phillips & Cohen LLP is the nation's most successful law firm representing whistleblowers. Qui tam lawsuits brought by Phillips & Cohen have resulted in civil and criminal recoveries totaling $5.3 billion. Phillips & Cohen also represents whistleblowers in cases involving major tax violations and securities laws violations. The firm's attorneys are regularly recognized for their successful work on whistleblower cases with inclusion on such select lists as the Top 10 "Winning Attorneys" in the U.S., the "100 Most Influential Lawyers" and the National Law Journal's Top 20 "Hot List" of plaintiffs' law firms. See www.phillipsandcohen.com.


'/>"/>
SOURCE Phillips & Cohen LLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Whistleblower Kickback Case Against Alpharma Results In $42.5 Million Recovery for U.S. and States
2. Pfizer Whistleblower Named Years Most Influential Person In Business Ethics
3. Whistleblowers Attorney Says Pfizers Guilty Plea Today Opens New Chapter on Aggressive Enforcement of Pharma Companies
4. The Time Is Right for Doctors to Go Digital
5. Free Prescription Coupons from FirstRxSavings.com Help Doctors to Evaluate Patients Reactions to Medications
6. New Research Gives Insight to the Frequency of Doctor Shopping Occurring Within Prescription Monitoring Programs
7. Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show
8. Long Island Doctor Shows First 4K Ultra-High Definition Surgery
9. E-CigaretteDirect.com Endorsed By Prominent Doctor
10. Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
11. Doctors Urge Precaution to Shield Against Swine Flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, affiliated ... Weintraub as a prominent plastic surgeon and the network’s newest partner. , ... most handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone ... executive with extensive sequencing and genomics experience, as Vice President of North American Capital ... will be responsible for leading the sales team in the commercialization of the HTG ...
Breaking Medicine News(10 mins):